Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$1.44 Mil
% of Total Estimate Gain
96.42%

SEVEN EIGHT CAPITAL, LP's ADMA Biologics Inc Holding Summary

As of 2024-12-31, SEVEN EIGHT CAPITAL, LP held - shares of ADMA Biologics Inc(ADMA), totaling N/A. This investment constitutes 0% of their stock portfolio, and SEVEN EIGHT CAPITAL, LP now holds 0% of the outstanding ADMA Biologics Inc(ADMA) stock.

The initial trade took place in 2024Q2. And since then SEVEN EIGHT CAPITAL, LP has made 1 purchases of ADMA, at an average price of $8.39, for a total of 178,203.00 shares. In addition, there have been 2 sales at an average price of $16.48 for 178,203.00 shares. Based on historical transaction data and ADMA's current price of $17.59, SEVEN EIGHT CAPITAL, LP's estimated gain on his ADMA holdings is $1.44 Mil, reflecting a 96.42% gain to date.

SEVEN EIGHT CAPITAL, LP ADMA ($17.59) Holding Chart

SEVEN EIGHT CAPITAL, LP ADMA ($17.59) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1